These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 723450)

  • 41. Single apomorphine pretreatment results in a rapid decline in high-affinity dopamine binding to the striatal dopamine D-2 receptor.
    Severson JA; Randall PK; Wilcox RE
    Eur J Pharmacol; 1990 Apr; 188(4-5):283-6. PubMed ID: 2114303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of flunarizine with dopamine D2 and D1 receptors.
    Ambrosio C; Stefanini E
    Eur J Pharmacol; 1991 May; 197(2-3):221-3. PubMed ID: 1833208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.
    Dubocovich ML; Zahniser NR
    Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
    [No Abstract]   [Full Text] [Related]  

  • 45. Dopamine D2 receptor binding properties of [3H]U-86170, a dopamine receptor agonist.
    Lahti RA; Evans DL; Figur LM; Carrigan KJ; Moon MW; Hsi RS
    Eur J Pharmacol; 1991 Sep; 202(2):289-91. PubMed ID: 1687034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Agonist binding to striatal dopamine receptors in aging. The ternary complex of receptor and guanine nucleotide binding regulatory protein.
    Severson JA; Wilcox RE
    Ann N Y Acad Sci; 1988; 515():178-90. PubMed ID: 2966604
    [No Abstract]   [Full Text] [Related]  

  • 47. Loss of rat striatal dopamine receptors with ageing is selective for D-2 but not D-1 sites: association with increased non-specific binding of the D-1 ligand [3H]piflutixol.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 105(1-2):171-4. PubMed ID: 6149143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG; Friedhoff AJ; Bonnet KA
    Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H; Sudo K; Sano M
    Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dopamine receptor binding is increased in diabetic rats.
    Lozovsky D; Saller CF; Kopin IJ
    Science; 1981 Nov; 214(4524):1031-3. PubMed ID: 6458088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
    Cass WA; Zahniser NR
    Synapse; 1990; 5(4):336-7. PubMed ID: 2141733
    [No Abstract]   [Full Text] [Related]  

  • 52. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
    Leff SE; Hamblin MW; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):171-83. PubMed ID: 3969066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transport of [3H]mazindol binding sites in mesostriatal dopamine axons.
    O'Dell SJ; Marshall JF
    Brain Res; 1988 Sep; 460(2):402-6. PubMed ID: 3147121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites.
    Morgan DG; Finch CE
    J Neurochem; 1986 May; 46(5):1623-31. PubMed ID: 2937884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preferential adsorption of dopamine antagonist binding sites by fluphenazine-agarose.
    Fong JC
    Proc Natl Sci Counc Repub China B; 1986 Apr; 10(2):113-7. PubMed ID: 3749364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristics of 3H-cis-flupenthixol binding in rat striatum.
    Murrin LC
    Life Sci; 1983 Nov; 33(22):2179-86. PubMed ID: 6645796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of dopamine receptors by endogenous amines: binding to striatal receptors and pharmacological effects on locomotor activity.
    Kawai H; Kotake Y; Ohta S
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1669-71. PubMed ID: 10937721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Binding sites for [3H]dopamine and dopamine-antagonists on cultured astrocytes of rat striatum and spinal cord: an autoradiographic study.
    Hösli E; Hösli L
    Neurosci Lett; 1986 Apr; 65(2):177-82. PubMed ID: 2940478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevation of acetylcholine levels in striatum of rat brain by LY163502, trans-(-)-5,5a,6,7,8,9a,10-octahydro-6-propylpyrimido less than 4,5-g greater than quinolin-2-amine dihydrochloride, a potent and stereospecific dopamine (D2) agonist.
    Bymaster FP; Reid LR; Nichols CL; Kornfeld EC; Wong DT
    Life Sci; 1986 Jan; 38(4):317-22. PubMed ID: 3753738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum.
    Allard PO; Eriksson K; Ross SB; Marcusson JO
    Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.